Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM1315MO2
TNBC
Basal B
Torkinib
15401.211
uM
-inf
0.00012
-0.9603 -0.8964 0.4331 1.6631
0.9588
0.4079
SUM1315MO2
TNBC
Basal B
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
10875.15
uM
0.60965
4.66480
-0.3108 -0.8213 0.4775 0.3610
0.9612
0.8527
SUM1315MO2
TNBC
Basal B
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12428.169
uM
3.01360
12.5950
-0.8598 -1.0000 0.7682 0.3878
0.9673
0.7851
SUM1315MO2
TNBC
Basal B
TPCA-1
IKK
NFKB
10381.093
uM
0.74301
1.23160
-0.4026 -0.4073 1.1791 0.4288
0.9942
0.9799
SUM1315MO2
TNBC
Basal B
Trametinib
MEK
MAPK
7529.05
uM
0.05070
0.05677
-0.0577 -0.0590 0.9862 0.4749
0.9651
0.4921
SUM1315MO2
TNBC
Basal B
Trametinib
MEK
MAPK
10139.012
uM
0.15977
0.58216
-0.2185 -0.3974 0.4523 0.3967
0.9658
0.8556
SUM1315MO2
TNBC
Basal B
Trametinib
MEK
MAPK
9797.012
uM
0.01756
0.02951
-0.3386 -0.2586 0.8029 0.6087
0.9686
0.4792
SUM1315MO2
TNBC
Basal B
Trichostatin A
HDAC
HDAC
7528.065
uM
44.86490
65.5740
-0.9054 -0.8543 2.6255 0.6553
0.9931
1.1128
SUM1315MO2
TNBC
Basal B
Trichostatin A
HDAC
HDAC
9044.065
uM
35.57120
53.06090
-1.0000 -1.0000 2.7472 0.7056
0.9961
0.5944
SUM1315MO2
TNBC
Basal B
Trichostatin A
HDAC
HDAC
10381.065
uM
47.60670
65.64780
-0.9168 -0.8928 3.1883 0.6130
0.9986
1.2390
SUM1315MO2
TNBC
Basal B
Triciribine
AKT
AKT
9044.074
uM
0.12505
0.26132
-0.1131 -0.2218 0.4981 0.4707
0.9829
0.6607
SUM1315MO2
TNBC
Basal B
Triciribine
AKT
AKT
7528.074
uM
0.96910
2.10810
0.0070 -0.2267 0.4811 0.3010
0.9908
1.0143
SUM1315MO2
TNBC
Basal B
Valproic acid
HDAC
HDAC
12428.143
uM
902.48790
1000.00000
-0.8280 -0.3352 5.0000 0.1793
0.8521
0.7057
SUM1315MO2
TNBC
Basal B
Valproic acid
HDAC
HDAC
10875.143
uM
744.6310
1000.00000
-0.8216 -0.4130 2.0418 0.2543
0.8722
0.8219
SUM1315MO2
TNBC
Basal B
Vinorelbine
TUBB
TUBB
9797.006
uM
0.00425
0.00528
-1.0000 -0.9693 4.9995 1.7533
0.9968
0.4196
SUM1315MO2
TNBC
Basal B
Vorinostat
HDAC
HDAC
9044.065
uM
82.98250
261.01970
-0.9871 -0.9939 0.9551 0.6403
0.9792
0.5944
SUM1315MO2
TNBC
Basal B
Vorinostat
HDAC
HDAC
7528.065
uM
131.72910
438.6910
-0.7595 -0.8756 0.8413 0.5743
0.9877
1.1128
SUM1315MO2
TNBC
Basal B
Vorinostat
HDAC
HDAC
10381.065
uM
212.2460
499.47260
-0.8654 -0.9079 1.2097 0.5192
0.9975
1.2390
SUM1315MO2
TNBC
Basal B
XRP44X
ELK3
MAPK
12428.157
uM
1.02840
0.98339
0.2789 0.1002 5.0000 0.3657
0.8404
0.9842
SUM1315MO2
TNBC
Basal B
XRP44X
ELK3
MAPK
10875.151
uM
0.42450
0.64818
-0.9033 -0.8837 2.4049 0.7977
0.9990
0.7096
SUM1315MO2
TNBC
Basal B
Z-Leu-Leu-Norvalinal
Proteasome
Proteasome
14281.189
uM
0.21395
0.34111
-0.9998 -0.9158 2.2313 0.8353
0.9788
0.4986
SUM1315MO2
TNBC
Basal B
ZM-447439
AURK
AURK
12428.169
uM
inf
inf
0.9057 0.9057 0.0000 0.0256
0.3399
0.7851
SUM1315MO2
TNBC
Basal B
ZM-447439
AURK
AURK
10875.15
uM
inf
0.00704
0.8585 0.8717 4.9959 0.0873
0.6578
0.8527
SUM149PT
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7917.016
uM
274.97130
946.23690
0.6414 -1.0000 0.8890 0.0413
0.9052
2.9532
SUM149PT
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
9830.019
uM
40.41620
63.43880
-0.8334 -1.0000 2.4368 0.1575
0.9930
1.9053